… was used: dacarbazine 220 mg/m 2 and cisplatin 25 mg/m 2 … weeks, carmustine 150 mg/m
2 iv every 6 weeks, tamoxifen 10 … scqod 3 times a wk Interferon alpha-2b 3.0 mu/m 2 scqod 3 …

… Summary In several phase II-trials encouraging tumour … of cisplatin, DTIC and carmustine
with iv IL-2 and sc IFNα in 83 … recombinant interleukin-2 and interferon-alpha 2b in advanced …

… phase II study 37 patients with metastatic melanoma were treated with cisplatin 100 mg/m2
every three weeks and interferon alpha-… with cisplatin, dacarbazine, and tamoxifen alone or in …

… % have been reported in phase II studies and 18.5% to 30% … phase II trial for first-line treatment
of metastatic melanoma … -2, and interferon alpha-2b in advanced melanoma outpatients: …

… of dacarbazine, carmustine, cisplatin, and tamoxifen citrate (… : A phase II study of
biochemotherapy using interleukin-2 and … cisplatin, vinblastine, and DTIC in patients with …

… -2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous
dacarbacine. cisplatin… Borden EC and Blum RH I1996) Interferon-alpha 2b adjusant therapy of …

… , levamisole, or combinations of these agents with dacarbazine, as adjuvant therapies for
treating stage II and III melanoma. The trials were largely underpowered and yielded negative …

… For many years drugs such as nitrosoureas, especially carmustine (… in the treatment of
metastatic melanoma [ 14,15 ]. The Italian … Cisplatin, dacarbazine with or without subcutaneous …

… Phase II trial of intralesional therapy with interleukin-2 in … Dacarbazine 220 mg/m 2 days
1–3; carmustine 150 mg/m 2 day 1 every second cycle; cisplatin 25 mg/m 2 days 1–3; tamoxifen …

… up to 50% objective remissions in metastatic melanoma, consists of the combination of
carmustine (BCNU), dacarbazine (DTIC), cisplatin (CDDP), and tamoxifen. The rationale for this …